| Institution: | 1. Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel;2. Division of Cardiovascular Medicine, TIMI Study Group, Brigham and Womenʼs Hospital and Harvard Medical School, Boston, Massachusetts;3. Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK;4. Department of Medicine, Li Ka Shing Knowledge Institute, St. Michaelʼs Hospital, University of Toronto, Toronto, Canada;5. Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, and Parkland Health and Hospital System, Dallas, Texas;6. Endocrinology Unit, Diabetes Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;7. University Medical Center Groningen and Bethesda Diabetes Research Center, Groningen, the Netherlands;8. BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden |
